ORIGINAL RESEARCH
Accepted on 28 Mar 2025
Quantitative adverse outcome pathway modeling for cigarette smoke-inducible airway mucus hypersecretion. Part 1: AOP-based in vitro assessment with repeated exposure to whole cigarette smoke Authors
doi 10.3389/ftox.2025.1564857